Search Page

1

Cite

Share

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Yoshida-Moriguchi T, Campbell KP. Yoshida-Moriguchi T, et al. Glycobiology. 2015 Jul;25(7):702-13. doi: 10.1093/glycob/cwv021. Epub 2015 Apr 16. Glycobiology. 2015. PMID: 25882296 Free PMC article. Review.

Cite

Share

2

Cite

Share

Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.

Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP. Inamori K, et al. Science. 2012 Jan 6;335(6064):93-6. doi: 10.1126/science.1214115. Science. 2012. PMID: 22223806 Free PMC article.

Cite

Share

3

Cite

Share

SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.

Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP. Yoshida-Moriguchi T, et al. Science. 2013 Aug 23;341(6148):896-9. doi: 10.1126/science.1239951. Epub 2013 Aug 8. Science. 2013. PMID: 23929950 Free PMC article.

Cite

Share

4

Cite

Share

Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.

Inamori K, Hara Y, Willer T, Anderson ME, Zhu Z, Yoshida-Moriguchi T, Campbell KP. Inamori K, et al. Glycobiology. 2013 Mar;23(3):295-302. doi: 10.1093/glycob/cws152. Epub 2012 Nov 2. Glycobiology. 2013. PMID: 23125099 Free PMC article.

Cite

Share

5

Cite

Share

The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.

Willer T, Inamori K, Venzke D, Harvey C, Morgensen G, Hara Y, Beltrán Valero de Bernabé D, Yu L, Wright KM, Campbell KP. Willer T, et al. Elife. 2014 Oct 3;3:e03941. doi: 10.7554/eLife.03941. Elife. 2014. PMID: 25279699 Free PMC article.

Cite

Share

6

Cite

Share

Glycomic analyses of mouse models of congenital muscular dystrophy.

Stalnaker SH, Aoki K, Lim JM, Porterfield M, Liu M, Satz JS, Buskirk S, Xiong Y, Zhang P, Campbell KP, Hu H, Live D, Tiemeyer M, Wells L. Stalnaker SH, et al. J Biol Chem. 2011 Jun 17;286(24):21180-90. doi: 10.1074/jbc.M110.203281. Epub 2011 Apr 1. J Biol Chem. 2011. PMID: 21460210 Free PMC article.

Cite

Share

7

Cite

Share

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, Mathews KD, Nelson SF, Moore SA, Campbell KP. Willer T, et al. Nat Genet. 2012 May;44(5):575-80. doi: 10.1038/ng.2252. Nat Genet. 2012. PMID: 22522420 Free PMC article.

Cite

Share

8

Cite

Share

Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex.

Lancioni A, Rotundo IL, Kobayashi YM, D'Orsi L, Aurino S, Nigro G, Piluso G, Acampora D, Cacciottolo M, Campbell KP, Nigro V. Lancioni A, et al. Hum Mol Genet. 2011 Dec 1;20(23):4644-54. doi: 10.1093/hmg/ddr398. Epub 2011 Sep 2. Hum Mol Genet. 2011. PMID: 21890494 Free PMC article.

Cite

Share

9

Cite

Share

Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L, Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A, Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC; UK10K Consortium, Stemple D, Lin YY, Muntoni F. Stevens E, et al. Am J Hum Genet. 2013 Mar 7;92(3):354-65. doi: 10.1016/j.ajhg.2013.01.016. Epub 2013 Feb 28. Am J Hum Genet. 2013. PMID: 23453667 Free PMC article.

Cite

Share

10

Cite

Share

Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse.

de Greef JC, Hamlyn R, Jensen BS, O'Campo Landa R, Levy JR, Kobuke K, Campbell KP. de Greef JC, et al. Hum Mol Genet. 2016 Apr 1;25(7):1357-69. doi: 10.1093/hmg/ddw018. Epub 2016 Jan 24. Hum Mol Genet. 2016. PMID: 26908621 Free PMC article.

Cite

Share